Carecloud Inc Stock Price, News & Analysis

CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has been added to the Russell Microcap® Index effective June 30, 2025. The company experienced significant growth with its stock price rising approximately 70% during Q2 2025.

Notable achievements include launching an AI Center of Excellence, resuming acquisition activities, and maintaining a strong cash position of $10 million at Q2 end. Additionally, approximately 3.5 million shares of Series A Preferred Stock were converted to Common Stock on March 6, 2025.

CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has announced reaching a significant milestone with a public float of $85.1 million as of June 30, 2025. This achievement triggers new SEC compliance requirements, specifically the need for auditor attestation of Internal Control over Financial Reporting (ICFR) under Sarbanes-Oxley Act Section 404(b).

The Company's current audit firm has indicated it lacks capacity to perform the required ICFR attestation. As SEC regulations mandate the same firm conduct both financial statement audit and ICFR attestation, CareCloud has initiated a search for a new audit firm to handle these responsibilities for fiscal year 2025.

CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, announced that its current independent registered public accounting firm may resign if the company requires an Internal Control over Financial Reporting (ICFR) attestation for fiscal year 2025.

The requirement for ICFR attestation will be determined by CareCloud's public float as of June 30, 2025. If it reaches or exceeds $75 million, the company will be classified as an accelerated filer, necessitating the attestation under Section 404(b) of the Sarbanes-Oxley Act. The current audit firm has stated it lacks capacity for ICFR attestation, which would require CareCloud to engage a new accounting firm as SEC rules mandate the same firm conduct both financial statement audit and ICFR attestation.

CareCloud (NASDAQ: CCLD) announced its participation in Maxim Group's 2025 Virtual Tech Conference, scheduled for June 3, 2025. The company's Co-CEOs will join the Healthcare IT Panel at 11:00 a.m. EDT to discuss how artificial intelligence is revolutionizing healthcare delivery across clinical decision support, administrative automation, and revenue optimization. The conference, hosted on M-Vest, will focus on how growth companies are utilizing transformative technologies like Quantum Computing and AI to ensure long-term success. The event will feature discussions between company executives and Maxim Group Senior Analysts, with registration required through M-Vest for attendance.

CareCloud (NASDAQ: CCLD) held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders approved three key proposals. The meeting resulted in the re-election of three board members - Anne Busquet, Bill Korn, and Lawrence Sharnak - for two-year terms. Shareholders also approved the compensation package for named executive officers and the appointment of Rosenberg Rich Baker Berman, P.A. as the company's independent registered public accounting firm for the fiscal year 2025.

The re-elected board members bring significant experience: Busquet has over 30 years of executive experience with American Express and Interactive Corp, Korn previously served as CareCloud's CFO for 10 years until October 2023, and Sharnak held various senior leadership roles during his 30-year tenure at American Express.

CareCloud (NASDAQ: CCLD) has been named the "Top Healthcare IT Pick for 2025" by Maxim Group, highlighting the company's AI strategy and strong financial performance. Maxim Group's analyst Allen Klee emphasized CareCloud's attractive valuation, noting it trades at a 2026 EV/EBITDA multiple of 5.0x, significantly below the peer group average of 12.5x.

The company reported impressive Q1 2025 results with 52% year-over-year adjusted EBITDA growth. CareCloud's recently launched AI Center of Excellence, starting with 50 AI professionals and planning to expand to 500 by year-end, demonstrates its commitment to AI integration. The company's AI suite includes tools like cirrusAI Notes, cirrusAI Appeals, and cirrusAI Voice, positioning CareCloud as a leader in healthcare AI solutions.

CareCloud (CCLD) reported strong Q1 2025 financial results with revenue of $27.6M (up 6% YoY) and GAAP net income of $1.9M (vs. loss of $241K in Q1 2024). The company achieved Adjusted EBITDA of $5.6M (52% increase) and adjusted net income of $2.3M. Key developments include launching an AI Center of Excellence with plans to scale to 500 AI specialists, completing Series A preferred stock conversion reducing annual dividend commitment by $7.7M, resuming preferred dividends, and completing two strategic acquisitions. CareCloud reaffirmed its 2025 guidance with expected revenue of $111-114M, Adjusted EBITDA of $26-28M, and EPS of $0.10-0.13.

CareCloud (CCLD) has announced monthly cash dividend payments for its Series A and Series B Preferred Stock for May and June 2025. Both series carry an 8.75% annual dividend rate on a $25.00 per share liquidation preference. The monthly dividend for both series is set at $0.18229 per share. Series A holders will receive an additional payment of $0.04688 per share, reflecting a 2.25% adjustment from a previous 11% dividend rate. The dividends will be paid on June 16, 2025, and July 15, 2025, with respective record dates of May 31 and June 30, 2025.

CareCloud (Nasdaq: CCLD) has launched its AI Center of Excellence (AI CoE), starting with 50 AI engineers, data scientists, and healthcare experts, with plans to expand to 500 AI professionals by Q4 2025. The initiative aims to become the world's largest dedicated healthcare AI center.

Operating under a dual-shore model, the self-funded AI CoE leverages CareCloud's 25 years of clinical and financial data to develop proprietary healthcare AI solutions. The center focuses on developing intelligent models for clinical workflows, revenue cycle processes, and decision support, while streamlining operations through automation.

Key focus areas include:

• Proprietary healthcare AI model development
• Automation of clinical documentation and claims management
• Predictive analytics for reimbursement risks
• AI-driven patient engagement enhancement
• Integration of AI across EHR and RCM platforms